AI assistant
Sending…
Chemours Co — Director's Dealing 2017
Oct 14, 2017
31561_dirs_2017-10-13_019e15d8-eb4c-4b55-a605-56039f5db2f9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2017-10-13
Reporting Person: Shelton David C (SVP, GC & Corp. Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-10-13 | Common Stock | M | 5908 | $15.49 | Acquired | 47356 | Direct |
| 2017-10-13 | Common Stock | S | 5908 | $56.01 | Disposed | 41448 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-10-13 | Stock Option (Right to Buy) | $15.49 | M | 5908 | Disposed | 2021-02-04 | Common Stock (5908) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 492 | Indirect |
Footnotes
F1: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2017.
F2: Shares were sold in multiple transactions at prices ranging from $56.00 to $56.04.
F3: Includes directly owned shares, unvested restricted stock units and dividend equivalent units.
More from Chemours Co
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3